PRAGUE.BIO MEMBERS PARTICIPATE IN BUSINESS MISSION WITH CZECH PRESIDENT IN SWITZERLAND
Prague, November 7, 2024 – Key representatives from Prague.bio, IOCB Tech and other leading members of the Czech biotech community, participated in a high-profile business mission in Switzerland, which accompanied the President of the Czech Republic, Petr Pavel, on his state visit. Organized by the Czech Chamber of Commerce, this mission aimed to deepen commercial and research partnerships between the Czech Republic and Switzerland, particularly in the fields of biotechnology, pharmaceuticals, and innovation.
Prague, November 7, 2024 – Key representatives from Prague.bio, IOCB Tech and other leading members of the Czech biotech community, participated in a high-profile business mission in Switzerland, which accompanied the President of the Czech Republic, Petr Pavel, on his state visit. Organized by the Czech Chamber of Commerce, this mission aimed to deepen commercial and research partnerships between the Czech Republic and Switzerland, particularly in the fields of biotechnology, pharmaceuticals, and innovation.
Switzerland, recognized globally for its leadership in biotech and pharmaceuticals, is an ideal partner for the Czech Republic’s rapidly growing biotech ecosystem. Over the three-day mission, the delegation visited Zurich, Basel, and Bern, where they engaged in forums, expert meetings, and institutional visits that highlight the mutual commitment to advancing science and technology.
In Zurich, the Czech delegation took part in a prestigious business forum at ETH Zurich, one of the world’s foremost technical universities. The event was inaugurated by President Petr Pavel and Swiss Confederation President Viola Amherd, featuring speakers such as Ruth Metzler-Arnold, President of Switzerland Global Enterprise, and Christoph Mäder, President of the Swiss Chamber of Commerce. The discussions focused on opportunities for collaboration between Czech and Swiss biotech companies, positioning Prague as an emerging biotech hub in Europe.
The mission continued in Basel, where delegates were touring the Biozentrum at the University of Basel, a center known for groundbreaking research in molecular biology and biotechnology. Global pharmaceutical giant Roche was also hosting the delegation for an exclusive visit, offering insights into cutting-edge research in biotech and pharmaceuticals. The agenda included a roundtable discussion on funding opportunities for biotech and life sciences, a key area of growth for both Switzerland and the Czech Republic.
"Switzerland represents an extraordinary opportunity for Prague.bio to connect with one of the most innovative biotech ecosystems in the world," says Petra Kinzlová, CEO of Prague.bio. "This mission was not just about strengthening commercial ties; it was about fostering collaborations that can drive scientific progress and bolster the international competitiveness of Czech biotech. By connecting with top Swiss institutions and industry leaders, we were opening doors for new ideas, partnerships, and growth."
This business mission also provides an invaluable platform for Prague.bio members to connect with influential partners in the biotech and pharmaceutical sectors, fostering a cross-border exchange of knowledge and innovative practices. One of Prague.bio members, company Kapaji, joined the mission as well.